Evidence map›Paper›PMID 42857443›Full record

ArticleHealth science reports2026

Impact of Implementing the Modified Assessment of the Difficulty of Intravenous Access Scale on First-Attempt Venous Access Success: Study Protocol for the Multicenter Prospective Before-and-After Controlled DIVAPERF Trial.

Mélanie Godiveau, Judith Passildas Jahanmohan, Mélanie Casile, Emilie Thivat, Alexia Giro, Céleste Pinard, Ioana Molnar, Caroline Jacquet, Mede-Line Courty, Florian Decombe and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06062199 (Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06062199 narecruitingnot on this map

Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt

TypeinterventionalSponsorCentre Jean PerrinRan2024 to 2028Enrolled200ConditionsChronic DiseaseArmsTraining in the A-DIVA scale and its failure prediction score
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mélanie GodiveauClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0009-0005-2905-8171
Judith Passildas JahanmohanClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0002-3575-7260
Mélanie CasileClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0002-7008-3732
Emilie ThivatClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0001-6833-1971
Alexia GiroClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0002-4035-8432
Céleste PinardClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0009-0009-8448-763X
Ioana MolnarClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0001-5114-2648
Caroline JacquetCentre Jean Perrin Clermont-Ferrand France.
Mede-Line CourtyCentre Jean Perrin Clermont-Ferrand France.
Florian DecombeCentre Jean Perrin Clermont-Ferrand France.
Hélène LaurentCentre Jean Perrin Clermont-Ferrand France.ORCID https://orcid.org/0000-0001-7008-0032
Marie-Agnès BourgCentre Jean Perrin Clermont-Ferrand France.
Catherine AbrialClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0002-1759-9457
Xavier DurandoClinical Research Division, Clinical Research and Innovation Delegation, Jean Perrin Center Comprehensive Cancer Center Clermont-Ferrand France.ORCID https://orcid.org/0000-0001-6035-3172
Lucie MadelaineCentre Jean Perrin Clermont-Ferrand France.ORCID https://orcid.org/0009-0002-6240-7554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Short peripheral catheter (SPC) insertion is crucial in nursing practice and is one of the primary routes for therapeutic administration. Despite its widespread use, this procedure can be challenging for patients with difficult venous access. The management of chronic or long-term pathologies and their associated therapies is directly conditioned by the success or failure of venous access. A Dutch study has developed a scoring system implementing criteria to predict the risk of failure of SPC insertion. This scoring system, derived from a two-phase study, identified clear predictive criteria for procedure success or failure, and demonstrated a direct correlation between the score and the probability of failure. This suggests the potential usefulness of implementing this system to improve initial patient assessment before SPC insertion. Methods: This is a two-phase interventional study evaluating the impact of the modified A-DIVA score on SPC insertion success. In the first phase, the investigator will assess practices by obtaining the modified A-DIVA score before each SPC insertion. In the second phase, nurses will receive training to apply the modified A-DIVA score and then will use the score before each insertion attempt. The primary outcome measure is the success rate for SPC insertion at first attempt in both groups. The DIVAPERF trial has been recruiting patients since February 2024 and recruitment is expected to end in December 2028. Results: This study will evaluate whether the implementation of modified A-DIVA score before each SPC insertion improves first-attempt success. Conclusion: It is hypothesized that the modified A-DIVA score will guide nurses to adjust their approach, improving first-attempt success rates. Trial and Protocol Registration: The DIVAPERF trial is registered with the French Medicines Agency (2023-A01480-45) and ClinicalTrials.gov (NCT06062199). Protocol V3.0 (02/04/2025).

Indexed as

clinical trialmedicinemodified A‐DIVA scoreperipheral venous catheterscoring systemvenous access devices

Identifiers

PMID42857443
PMCPMC13650512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.